PARIS, June 9, 2020 /PRNewswire/ -- Stilla Technologies, a leading provider of digital PCR (dPCR) solutions for high-precision genetic analysis, today launched the world's first six-color digital PCR ...
Designed with a scalable architecture, the QuantStudio™ 3D Digital PCR System's first generation chips enable up to 20,000 data points in a single run — coverage that satisfies the needs for most ...
FOSTER CITY, Calif. & HAMBURG, Germany--(BUSINESS WIRE)--Nov. 11, 2005--Applied Biosystems Group (NYSE:ABI), an Applera Corporation business, today announced it has granted a worldwide, ...
Roche (SIX: RO, ROG; OTCQX: RHHBY) announced today the introduction of a new protein melting application for its high-throughput, real-time PCR LightCycler® 1536 instrument. The fully automated ...
Roche and Precision System Science, Co., Ltd (PSS) today announced the signing of an exclusive agreement to develop and manufacture a fully automated emulsion PCR instrument for Roche's portfolio of ...
The Pharos V8 is based on the company’s patented Pulse Controlled Amplification (PCA) technology. Conventional PCR platforms rely on thermocyclers that the firm said can limit reaction speed. PCA uses ...
The polymerase chain reaction (PCR), invented about three decades ago, soon entered mainstream use thanks to an ongoing series of refinements. One particularly important refinement, introduced about ...
The Pharos V8 is a laser PCR (polymerase chain reaction) instrument powered by pulse-controlled amplification (PCA) technology. It features ultrafast nucleic acid amplification and microcyclers that ...
SUNNYVALE, Calif., Dec. 15, 2020 /PRNewswire/ -- Anitoa Systemc, LLC., market leader in rapid, portable PCR-based molecular testing, today announced the award of CE (Conformité Européene)-IVD Mark for ...
SALT LAKE CITY--(BUSINESS WIRE)--The U.S. Patent and Trademark Office has granted U.S. Patent No. 7,670,832, reaching claims that apply to most of the real-time PCR instruments on the market. Idaho ...
The global molecular diagnostics market is projected to reach $31.8 billion by 2026, up from $17.8 billion in 2021, with the polymerase chain reaction (PCR) segment accounting for the largest share, ...
Featuring a simple workflow with minimal hands-on time, the benchtop platform is disruptively priced at $30,000 -- enabling access to a broader community. The system is currently with early access ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback